Bipolar disorder trials recruiting in Pennsylvania

All Bipolar disorder trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
  NCT07172516 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Pennsylvania: Allentown
• A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
  NCT07286175 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
  NCT06920940 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 21 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Children's Bipolar Network Treatment Trial I
  NCT05427123 · Phase: Not specified · Ages: 9 Years to 19 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
  NCT07389473 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
  NCT06081426 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
  NCT05157620 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
  NCT06274567 · Phase: Not applicable (e.g. observational or device study) · Ages: 24 Years to 65 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
  NCT07494305 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
  NCT07220460 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Pennsylvania: Allentown
• Taking Action for College Students
  NCT06700902 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia